Can losartan, hydrochlorothiazide, clonidine, or alendronate cause otalgia (ear pain)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can These Medications Cause Ear Pain?

None of these four medications—losartan, hydrochlorothiazide, clonidine, or alendronate—are established causes of otalgia (ear pain) based on current clinical guidelines and high-quality evidence.

Hydrochlorothiazide and Hearing Disorders

While hydrochlorothiazide does not typically cause ear pain, there is emerging evidence of a potential association with hearing disorders:

  • A 2018 case series identified 94 reports of hearing disorders associated with hydrochlorothiazide in the WHO global adverse drug reaction database, with a median time to onset of 3 days and reversibility in 66.7% of cases 1
  • The reaction was marked as "serious" in 36% of cases, and in 26 cases, hearing disorder occurred following hydrochlorothiazide as the sole medication 1
  • However, this represents hearing loss or vestibular symptoms rather than otalgia specifically 1
  • Loop diuretics like furosemide are well-established ototoxic agents, but thiazide diuretics like hydrochlorothiazide have a different mechanism and lower ototoxic risk 2

Losartan Safety Profile

  • The most common adverse effect of losartan is dizziness, with an overall withdrawal rate due to adverse effects (2.3%) lower than placebo (3.7%) 3
  • Postmarketing surveillance has identified angioedema as a rare but serious adverse effect, but ear pain is not documented 3
  • The ACC/AHA hypertension guidelines do not list otalgia among the adverse effects of ARBs like losartan 4

Alendronate Adverse Effects

  • Alendronate's adverse events are predominantly upper gastrointestinal, including abdominal pain, nausea, dyspepsia, and esophageal reactions—not otalgia 5
  • Musculoskeletal pain is reported but refers to bone/joint pain, not ear pain 5
  • The ASCO osteoporosis guidelines discuss osteonecrosis of the jaw as a rare serious adverse effect of bisphosphonates, but this is distinct from otalgia 4

Clonidine Considerations

  • Clonidine is not mentioned in any of the provided evidence as causing ear pain
  • The ACC/AHA guidelines list clonidine among secondary antihypertensive agents but do not associate it with otalgia 4

Clinical Approach to Ear Pain in Patients on These Medications

When a patient on these medications presents with ear pain, consider:

  • Primary otalgia from otitis media or otitis externa is far more common than drug-induced ear pain 6
  • Secondary otalgia from temporomandibular joint syndrome, dental infections, or referred pain from other structures is more common in adults 6, 4
  • Examine the ear with pneumatic otoscopy to identify primary causes like acute otitis media or acute otitis externa 4
  • In patients over 50 with risk factors (smoking, alcohol use, diabetes), consider serious causes like temporal arteritis or malignancy that may require imaging or ENT consultation 6

Important Caveat

If ear pain develops in a patient taking hydrochlorothiazide along with other hearing symptoms (tinnitus, hearing loss, vertigo), consider hydrochlorothiazide-associated hearing disorder and evaluate for medication discontinuation 1. However, isolated otalgia without hearing changes is unlikely to be drug-related and warrants standard evaluation for primary or secondary causes 4.

References

Research

Hydrochlorothiazide and risk of hearing disorder: a case series.

Journal of medical case reports, 2018

Research

Drug-induced hearing loss.

Prescrire international, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ear Pain: Diagnosing Common and Uncommon Causes.

American family physician, 2018

Related Questions

What is the appropriate diagnosis and treatment for a 17-year-old female with ear pain and muffled hearing?
How to manage hypertension in a patient on Losartan 25mg bid and Metoprolol 25mg bid with blood pressure 190/103 mmHg?
What is the first-line osteoporosis medication for a patient with a history of breast cancer: Evista (raloxifene), Fosamax (alendronate), or Forteo (teriparatide) or estrogen?
What is the appropriate workup and treatment for a 22-year-old male presenting to the emergency room (ER) with otalgia (ear pain)?
How to manage a patient with persistent hypertension on losartan 25mg?
What once‑daily, pregnancy‑compatible antihypertensive regimen is recommended for a 26‑year‑old woman with hypertension planning pregnancy who frequently misses the evening labetalol dose?
Is it normal for a healthy adult male's testes to feel markedly smaller and softer the day after ejaculation?
What dose adjustment of acotiamide is recommended for patients with mild‑to‑moderate hepatic impairment, and should it be used in severe hepatic impairment?
Can a peri‑ampullary adenoma cause a bowel obstruction, such as duodenal or gastric‑outlet obstruction?
In a patient with an indwelling Foley catheter who develops dark (amber/brown) urine and abdominal distension, what is the appropriate evaluation and management?
Is my understanding of the current NTEP/WHO guidelines for diagnosing and treating tuberculosis—using sputum CBNAAT (Cartridge‑Based Nucleic Acid Amplification Test) for initial classification, the standard 2‑month HRZE (isoniazid, rifampicin, pyrazinamide, ethambutol) plus 4‑month HR (isoniazid, rifampicin) regimen for drug‑sensitive TB, definitions of RR‑TB (rifampicin‑resistant TB), MDR‑TB (multidrug‑resistant TB), pre‑XDR‑TB, XDR‑TB, baseline investigations before drug‑resistant TB therapy, and the three regimen categories (BPaLM, short standardized, long individualized) for drug‑resistant TB—correct?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.